FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jane Salmon

Research Profile

Chemicals & Drugs

Disorders

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Priya Darshinee A Issuree; Lionel B Ivashkiv; George D Kalliolias; Philipp A Lang; Tak W Mak; Thorsten Maretzky; David R McIlwain; Sébastien Monette; Kyung-Hyun Park-Min; Xiaoping Qing; Jane E Salmon; Steven L Swendeman; Anna Yarilina; Nikolaus Binder; Keisuke Horiuchi; Carl P Blobel
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
Xiaoping Qing; Gloria C Koo; Jane E Salmon
Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.
Michael D Lockshin; Joan Merrill; Michelle Petri; T Flint Porter; D Ware Branch; Jill Buyon; Marta Guerra; Mimi Kim; Carl A Laskin; Lisa Sammaritano; Mary D Stephenson; Jane E Salmon
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jane Salmon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Priya Darshinee A Issuree; Lionel B Ivashkiv; George D Kalliolias; Philipp A Lang; Tak W Mak; Thorsten Maretzky; David R McIlwain; Sébastien Monette; Kyung-Hyun Park-Min; Xiaoping Qing; Jane E Salmon; Steven L Swendeman; Anna Yarilina; Nikolaus Binder; Keisuke Horiuchi; Carl P Blobel
iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
The Journal of clinical investigation 2013;123(2):928-32.
2012: Xiaoping Qing; Gloria C Koo; Jane E Salmon
Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-β1 in Gr-1+ myeloid cells.
European journal of immunology 2012;42(7):1723-34.
2012: Michael D Lockshin; Joan Merrill; Michelle Petri; T Flint Porter; D Ware Branch; Jill Buyon; Marta Guerra; Mimi Kim; Carl A Laskin; Lisa Sammaritano; Mary D Stephenson; Jane E Salmon
Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.
Arthritis and rheumatism 2012;64(7):2311-8.
2012: Jessica R Berman; William L Cats-Baril; Juliet Aizer; Anne R Bass; Edward J Parrish; Laura Robbins; Jane E Salmon; Stephen A Paget
Building a rheumatology education academy: insights from assessment of needs during a rheumatology division retreat.
The Journal of rheumatology 2012;39(6):1280-6.
2012: Anne M Lynch; James R Murphy; Jane E Salmon; Nancy A West; Robert H Eckel; Ronald S Gibbs; Patricia C Giclas; V Michael Holers
Prepregnancy obesity and complement system activation in early pregnancy and the subsequent development of preeclampsia.
American journal of obstetrics and gynecology 2012;206(5):428.e1-8.
2012: Su Jin Kim; Kyriakos Kirou; Pretima Persad; Doruk Erkan; Roberta Horton; Jane E Salmon
Research studies and their implications for social work practice in a multidisciplinary center for lupus care.
Social work in health care 2012;51(7):652-60.
2011: Danieli Andrade; Giorgio Perino; Xiaoping Qing; Patricia B Redecha; Jane E Salmon; Milena Vukelic; Gloria C Koo
Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.
Arthritis and rheumatism 2011;63(9):2764-73.
2011: Jane E Salmon; Cara Heuser; Michael Triebwasser; M Kathryn Liszewski; David Kavanagh; Lubka Roumenina; D Ware Branch; Tim Goodship; Veronique Fremeaux-Bacchi; John P Atkinson
Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort.
PLoS medicine 2011;8(3):e1001013.
2011: Xiaoping Qing; Patricia B Redecha; Melissa A Burmeister; Stephen Tomlinson; Vivette D D'Agati; Robin L Davisson; Jane E Salmon
Targeted inhibition of complement activation prevents features of preeclampsia in mice.
Kidney international 2011;79(3):331-9.
2011: Anne M Lynch; Ronald S Gibbs; James R Murphy; Patricia C Giclas; Jane E Salmon; V Michael Holers
Early elevations of the complement activation fragment C3a and adverse pregnancy outcomes.
Obstetrics and gynecology 2011;117(1):75-83.
2011: Weijia Yuan; Stephen J DiMartino; Patricia B Redecha; Lionel B Ivashkiv; Jane E Salmon
Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Arthritis and rheumatism 2011;63(1):212-8.
2010: A M Lynch; Jane E Salmon
Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.
Placenta 2010;31(7):561-7.
2010: Shari E Gelber; Jane E Salmon
Autoimmunity: effectiveness of treatments for pregnant women with APS.
Nature reviews. Rheumatology 2010;6(4):187-9.
2010: Anne M Lynch; J R Murphy; R S Gibbs; Richard J Levine; P C Giclas; Jane E Salmon; V Michael Holers
The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.
BJOG : an international journal of obstetrics and gynaecology 2010;117(4):456-62.
2008: Jane E Salmon; Mary J Roman
Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
The American journal of medicine 2008;121(10 Suppl 1):S3-8.
2008: Stephen J DiMartino; Weijia Yuan; Patricia B Redecha; Lionel B Ivashkiv; Jane E Salmon
Insoluble immune complexes are most effective at triggering IL-10 production in human monocytes and synergize with TLR ligands and C5a.
Clinical immunology (Orlando, Fla.) 2008;127(1):56-65.
2008: Deborah Alpert; Lisa A Mandl; Doruk Erkan; W Yin; E I Peerschke; Jane E Salmon
Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Annals of the rheumatic diseases 2008;67(3):395-401.
2008: Kristina Belostocki; Luminita Pricop; Patricia B Redecha; Ani Aydin; Linda Leff; Melanie J Harrison; Jane E Salmon
Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
Arthritis and rheumatism 2008;58(2):384-8.
2008: Jane E Salmon; Guillermina Girardi
Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation.
Journal of reproductive immunology 2008;77(1):51-6.
2007: Mary J Roman; Jane E Salmon
Cardiovascular manifestations of rheumatologic diseases.
Circulation 2007;116(20):2346-55.
2007: Mary J Roman; Mary Crow; Michael D Lockshin; Richard B Devereux; Stephen A Paget; Lisa Sammaritano; Daniel M Levine; Adrienne Davis; Jane E Salmon
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
Arthritis and rheumatism 2007;56(10):3412-9.
2007: Patricia B Redecha; Rachel E Tilley; Michael Tencati; Jane E Salmon; Daniel Kirchhofer; Nigel Mackman; Guillermina Girardi
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury.
Blood 2007;110(7):2423-31.
2007: Deborah Alpert; Adrienne Davis; Doruk Erkan; Mary J Roman; Jane E Salmon
Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus.
Nature clinical practice. Rheumatology 2007;3(8):473-8; quiz, 2nd following 478.
2007: Janice Pieretti; Mary J Roman; Richard B Devereux; Michael D Lockshin; Mary Crow; Stephen A Paget; Joseph E Schwartz; Lisa Sammaritano; Daniel M Levine; Jane E Salmon
Systemic lupus erythematosus predicts increased left ventricular mass.
Circulation 2007;116(4):419-26.
2007: Rashmi Sood; Mark Zogg; Randal J Westrick; Yi-He Guo; Edward J Kerschen; Guillermina Girardi; Jane E Salmon; Shaun R Coughlin; Hartmut Weiler
Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.
The Journal of experimental medicine 2007;204(5):1049-56.
2007: Jane E Salmon; Guillermina Girardi; Michael D Lockshin
The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients.
Nature clinical practice. Rheumatology 2007;3(3):140-7; quiz 1 p following 187.
2007: Eric Meffre; Jane E Salmon
Autoantibody selection and production in early human life.
The Journal of clinical investigation 2007;117(3):598-601.
2006: Afshin Farzaneh-Far; Mary J Roman; Michael D Lockshin; Richard B Devereux; Stephen A Paget; Mary Crow; Adrienne Davis; Lisa Sammaritano; Daniel M Levine; Jane E Salmon
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
Arthritis and rheumatism 2006;54(12):3918-25.
2006: Guillermina Girardi; Dmitry Yarilin; Joshua M Thurman; V Michael Holers; Jane E Salmon
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction.
The Journal of experimental medicine 2006;203(9):2165-75.
2006: Jane E Salmon; Deborah Alpert
Are we coming to terms with tumor necrosis factor inhibition in pregnancy?
Arthritis and rheumatism 2006;54(8):2353-5.
2006: Mary J Roman; Elfi Moeller; Adrienne Davis; Stephen A Paget; Mary Crow; Michael D Lockshin; Lisa Sammaritano; Richard B Devereux; Joseph E Schwartz; Daniel M Levine; Jane E Salmon
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis.
Annals of internal medicine 2006;144(4):249-56.
2006: Kyriakos A Kirou; Jane E Salmon; Mary Crow
Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system.
Rheumatic diseases clinics of North America 2006;32(1):103-19, ix.
2006: Guillermina Girardi; Roberta Bulla; Jane E Salmon; Francesco Tedesco
The complement system in the pathophysiology of pregnancy.
Molecular immunology 2006;43(1-2):68-77.
2005: Kristina Belostocki; Mee-Soon Park; Patricia B Redecha; Emi Masuda; Jane E Salmon; Luminita Pricop
FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils.
Clinical immunology (Orlando, Fla.) 2005;117(1):78-86.
2005: Mary J Roman; Richard B Devereux; Joseph E Schwartz; Michael D Lockshin; Stephen A Paget; Adrienne Davis; Mary Crow; Lisa Sammaritano; Daniel M Levine; Beth-Ann Shankar; Elfi Moeller; Jane E Salmon
Arterial stiffness in chronic inflammatory diseases.
Hypertension 2005;46(1):194-9.
2005: Jessica Berman; Guillermina Girardi; Jane E Salmon
TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(1):485-90.
2004: Guillermina Girardi; Patricia B Redecha; Jane E Salmon
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
Nature medicine 2004;10(11):1222-6.
2004: Jane E Salmon
A noninflammatory pathway for pregnancy loss: innate immune activation?
The Journal of clinical investigation 2004;114(1):15-7.
2004: Jane E Salmon; Guillermina Girardi
The role of complement in the antiphospholipid syndrome.
Current directions in autoimmunity 2004;7():133-48.
2003: Mary J Roman; Beth-Ann Shanker; Adrienne Davis; Michael D Lockshin; Lisa Sammaritano; Ronit Simantov; Mary Crow; Joseph E Schwartz; Stephen A Paget; Richard B Devereux; Jane E Salmon
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
The New England journal of medicine 2003;349(25):2399-406.
2003: Guillermina Girardi; Jessica Berman; Patricia B Redecha; Lynn Spruce; Joshua M Thurman; Damian Kraus; Travis J Hollmann; Paolo Casali; Michael C Caroll; Rick A Wetsel; John D Lambris; V Michael Holers; Jane E Salmon
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.
The Journal of clinical investigation 2003;112(11):1644-54.
2003: Jong-Dae Ji; Ioannis Tassiulas; Kyung-Hyun Park-Min; Ani Aydin; Ingrid Mecklenbrauker; Alexander Tarakhovsky; Luminita Pricop; Jane E Salmon; Lionel B Ivashkiv
Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis.
The Journal of experimental medicine 2003;197(11):1573-83.
2003: Luis Zuniga-Montes; Glen S Markowitz; Thaschawee Arkachaisri; Edward A Imperatore; Vivette D D'Agati; Jane E Salmon
Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.
Arthritis and rheumatism 2003;48(2):460-70.
2003: Jane E Salmon; Guillermina Girardi; V Michael Holers
Activation of complement mediates antiphospholipid antibody-induced pregnancy loss.
Lupus 2003;12(7):535-8.
2002: Jane E Salmon; Guillermina Girardi; V Michael Holers
Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.
Annals of the rheumatic diseases 2002;61 Suppl 2():ii46-50.
2002: Luminita Pricop; L Li; Jane E Salmon; Chaim O Jacob
Characterization of the FcgammaRIIA promoter and 5'UTR sequences in patients with systemic lupus erythematosus.
Genes and immunity 2002;3 Suppl 1():S47-50.
2002: Jeffrey C Edberg; Carl D Langefeld; Jianming Wu; Kathy L Moser; Kenneth M Kaufman; Jennifer Kelly; Vipin Bansal; W Mark Brown; Jane E Salmon; Stephen S Rich; John B Harley; Robert P Kimberly
Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.
Arthritis and rheumatism 2002;46(8):2132-40.
2002: Luminita Pricop; Jane E Salmon
Redox regulation of Fcgamma receptor-mediated phagocytosis: implications for host defense and tissue injury.
Antioxidants & redox signaling 2002;4(1):85-95.
2002: V Michael Holers; Guillermina Girardi; Lian Mo; Guthridge Joel; Hector Molina; Silvia S Pierangeli; Ricardo G Espinola; Liu E Xiaowei; Dailing Mao; Christopher G Vialpando; Jane E Salmon
Complement C3 activation is required for antiphospholipid antibody-induced fetal loss.
The Journal of experimental medicine 2002;195(2):211-20.
2001: L Mo; Jane E Salmon
Intercellular adhesion molecule 1 expression is required for antiphospholipid antibody-induced pregnancy loss.
Arthritis and rheumatism 2001;44(5):1225-6.
2001: Silvia S Pierangeli; Ricardo G Espinola; Xiaowei Liu; E Nigel Harris; Jane E Salmon
Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype.
Arthritis and rheumatism 2001;44(4):876-83.
2001: Jane E Salmon; Luminita Pricop
Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease.
Arthritis and rheumatism 2001;44(4):739-50.
2001: Mary J Roman; Jane E Salmon; R Sobel; Michael D Lockshin; Lisa Sammaritano; J E Schwartz; R B Devereux
Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome.
The American journal of cardiology 2001;87(5):663-6, A11.
2001: Luis Zuniga-Montes; S Ng; Margaret G E Peterson; J D Reveille; Bruce Baethge; G S Alarcón; Jane E Salmon
Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients.
Arthritis and rheumatism 2001;44(2):361-7.
2001: HR Yun; H K Koh; S S Kim; Won Tae Chung; D W Kim; K P Hong; Gwan Gyu Song; H K Chang; Jung-Yoon Choe; Sang-Cheol Bae; Jane E Salmon; Dae-Hyun Yoo; T Y Kim; S Y Kim
FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.
Lupus 2001;10(7):466-72.
2001: Luminita Pricop; Patricia B Redecha; J L Teillaud; J Frey; W H Fridman; C Sautès-Fridman; Jane E Salmon
Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):531-7.
2000: AM Yee; H M Phan; Luis Zuniga-Montes; Jane E Salmon; D M Musher
Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(1):25-8.
1999: N Hirose; R Williams; A R Alberts; Richard Furie; E K Chartash; RI Jain; Cristina P Sison; Robert G Lahita; Joan T Merrill; Elena Cucurull; Azzudin E Gharavi; Lisa Sammaritano; Jane E Salmon; S Hashimoto; T Sawada; Charles C Chu; Peter K Gregersen; Nicholas Chiorazzi
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.
Arthritis and rheumatism 1999;42(8):1655-61.
1999: Luminita Pricop; J Gokhale; Patricia B Redecha; S C Ng; Jane E Salmon
Reactive oxygen intermediates enhance Fc gamma receptor signaling and amplify phagocytic capacity.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(12):7041-8.
1999: Jane E Salmon; S Ng; D H Yoo; T H Kim; S Y Kim; Gwan Gyu Song
Altered distribution of Fcgamma receptor IIIA alleles in a cohort of Korean patients with lupus nephritis.
Arthritis and rheumatism 1999;42(4):818-9.
1998: Cynthia F Norris; Luminita Pricop; S S Millard; S M Taylor; Saul Surrey; E Schwartz; Jane E Salmon; Steven E McKenzie
A naturally occurring mutation in Fc gamma RIIA: a Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor.
Blood 1998;91(2):656-62.
1997: Lisa Sammaritano; S Ng; R Sobel; S K Lo; Ronit Simantov; Richard Furie; A Kaell; Roy L Silverstein; Jane E Salmon
Anticardiolipin IgG subclasses: association of IgG2 with arterial and/or venous thrombosis.
Arthritis and rheumatism 1997;40(11):1998-2006.
1997: L A Haseley; J J Wisnieski; M R Denburg; A R Michael-Grossman; E M Ginzler; Mark Gourley; J H Hoffman; Robert P Kimberly; Jane E Salmon
Antibodies to C1q in systemic lupus erythematosus: characteristics and relation to Fc gamma RIIA alleles.
Kidney international 1997;52(5):1375-80.
1997: Jianming Wu; Jeffrey C Edberg; Patricia B Redecha; V Bansal; Paul M Guyre; K Coleman; Jane E Salmon; Robert P Kimberly
A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.
The Journal of clinical investigation 1997;100(5):1059-70.
1997: Luminita Pricop; Jane E Salmon; Jeffrey C Edberg; A J Beavis
Flow cytometric quantitation of attachment and phagocytosis in phenotypically-defined subpopulations of cells using PKH26-labeled Fc gamma R-specific probes.
Journal of immunological methods 1997;205(1):55-65.
1997: AM Yee; S C Ng; R E Sobel; Jane E Salmon
Fc gammaRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus.
Arthritis and rheumatism 1997;40(6):1180-2.
1996: R Simantov; S K Lo; Jane E Salmon; Lisa Sammaritano; Roy L Silverstein
Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies.
Thrombosis research 1996;84(5):361-5.
1996: R Simantov; S K Lo; A Gharavi; Lisa Sammaritano; Jane E Salmon; Roy L Silverstein
Antiphospholipid antibodies activate vascular endothelial cells.
Lupus 1996;5(5):440-1.
1996: Jane E Salmon; S Millard; L A Schachter; Frank C Arnett; E M Ginzler; Mark Gourley; R Ramsey-Goldman; M G Peterson; Robert P Kimberly
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.
The Journal of clinical investigation 1996;97(5):1348-54.
1995: R Simantov; J M LaSala; S K Lo; A E Gharavi; Lisa Sammaritano; Jane E Salmon; Roy L Silverstein
Activation of cultured vascular endothelial cells by antiphospholipid antibodies.
The Journal of clinical investigation 1995;96(5):2211-9.
1995: Jane E Salmon; S S Millard; N L Brogle; Robert P Kimberly
Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner.
The Journal of clinical investigation 1995;95(6):2877-85.
1995: Robert P Kimberly; Jane E Salmon; Jeffrey C Edberg
Receptors for immunoglobulin G. Molecular diversity and implications for disease.
Arthritis and rheumatism 1995;38(3):306-14.
1993: Jane E Salmon; N Brogle; C Brownlie; Jeffrey C Edberg; Robert P Kimberly; Bi-Xing Chen; Bernard F Erlanger
Human mononuclear phagocytes express adenosine A1 receptors. A novel mechanism for differential regulation of Fc gamma receptor function.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(5):2775-85.
1992: A J Porges; P B Redecha; R Doebele; L C Pan; Jane E Salmon; Robert P Kimberly
Novel Fc gamma receptor I family gene products in human mononuclear cells.
The Journal of clinical investigation 1992;90(5):2102-9.
1992: Jane E Salmon; Jeffrey C Edberg; N L Brogle; Robert P Kimberly
Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function.
The Journal of clinical investigation 1992;89(4):1274-81.
1992: Jeffrey C Edberg; Jane E Salmon; Robert P Kimberly
Functional capacity of Fc gamma receptor III (CD16) on human neutrophils.
Immunologic research 1992;11(3-4):239-51.
1991: Jane E Salmon; N L Brogle; Jeffrey C Edberg; Robert P Kimberly
Fc gamma receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fc gamma receptor II.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(3):997-1004.
1991: Jeffrey C Edberg; Jane E Salmon; M Whitlow; Robert P Kimberly
Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
The Journal of clinical investigation 1991;87(1):58-67.
1990: Jane E Salmon; Bruce N Cronstein
Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(7):2235-40.
1990: Jeffrey C Edberg; M Barinsky; P B Redecha; Jane E Salmon; Robert P Kimberly
Fc gamma RIII expressed on cultured monocytes is a N-glycosylated transmembrane protein distinct from Fc gamma RIII expressed on natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(12):4729-34.
1990: Jane E Salmon; Jeffrey C Edberg; Robert P Kimberly
Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities.
The Journal of clinical investigation 1990;85(4):1287-95.
1990: J Laurence; S K Sikder; S Jhaveri; Jane E Salmon
Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: blockade by protein kinase inhibitors and relationship to tat-directed trans-activation.
Biochemical and biophysical research communications 1990;166(1):349-57.
1989: Robert P Kimberly; Jane E Salmon; Jeffrey C Edberg; Allan Gibofsky
The role of Fc gamma receptors in mononuclear phagocyte system function.
Clinical and experimental rheumatology 1989;7 Suppl 3():S103-8.
1989: Jeffrey C Edberg; P B Redecha; Jane E Salmon; Robert P Kimberly
Human Fc gamma RIII (CD16). Isoforms with distinct allelic expression, extracellular domains, and membrane linkages on polymorphonuclear and natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(5):1642-9.
1989: Jane E Salmon; S Kapur; N L Meryhew; O A Runquist; R P Kimberly
High-dose, pulse intravenous methylprednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus.
Arthritis and rheumatism 1989;32(6):717-25.
1987: Jane E Salmon; S Kapur; Robert P Kimberly
Opsonin-independent ligation of Fc gamma receptors. The 3G8-bearing receptors on neutrophils mediate the phagocytosis of concanavalin A-treated erythrocytes and nonopsonized Escherichia coli.
The Journal of experimental medicine 1987;166(6):1798-813.
1987: Jane E Salmon; S Kapur; R P Kimberly
Gammaglobulin for intravenous use induces an Fc gamma receptor-specific decrement in phagocytosis by blood monocytes.
Clinical immunology and immunopathology 1987;43(1):23-33.
1986: Jane E Salmon; R P Kimberly
Phagocytosis of concanavalin A-treated erythrocytes is mediated by the Fc gamma receptor.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(2):456-62.
1986: Jane E Salmon; Robert P Kimberly; Allan Gibofsky; M Fotino
Altered phagocytosis by monocytes from HLA-DR2 and DR3-positive healthy adults is Fc gamma receptor specific.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(10):3625-30.
1986: Robert P Kimberly; Jane E Salmon; Allan Gibofsky
Methyldopa and reticuloendothelial function.
The New England journal of medicine 1986;314(4):248-9.
1984: Jane E Salmon; Robert P Kimberly; Allan Gibofsky; M Fotino
Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(5):2525-31.
1984: R P Kimberly; Jane E Salmon; J B Bussel; Mary Crow; M W Hilgartner
Modulation of mononuclear phagocyte function by intravenous gamma-globulin.
Journal of immunology (Baltimore, Md. : 1950) 1984;132(2):745-50.
1983: Robert P Kimberly; Allan Gibofsky; Jane E Salmon; M Fotino
Impaired fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and MT1-positive healthy young adults.
The Journal of experimental medicine 1983;157(5):1698-703.